Inflammatory Bowel Diseases

Cover image for Vol. 13 Issue 4

April 2007

Volume 13, Issue 4

Pages 367–510

  1. Original Articles

    1. Top of page
    2. Original Articles
    3. Basic Science Review
    4. Selected Summaries
    5. Letters to the Editor
    1. 5-Aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease (pages 367–371)

      Jonathan P. Terdiman, Michael Steinbuch, William A. Blumentals, Thomas A. Ullman and David T. Rubin

      Version of Record online: 19 DEC 2006 | DOI: 10.1002/ibd.20074

    2. Predictive model for the outcome of infliximab therapy in Crohn's disease based on apoptotic pharmacogenetic index and clinical predictors (pages 372–379)

      Tibor Hlavaty, Marc Ferrante, Liesbet Henckaerts, Marie Pierik, Paul Rutgeerts and Severine Vermeire

      Version of Record online: 19 DEC 2006 | DOI: 10.1002/ibd.20024

    3. Fecal excretion of deoxyribonucleic acid in long-term follow-up of patients with inactive ulcerative colitis (pages 386–390)

      Francesc Casellas, Natalia Borruel, Maria Antolín, Encarnación Varela, Antonio Torrejón, Lluis Armadans, Francisco Guarner and Juan-R. Malagelada

      Version of Record online: 19 DEC 2006 | DOI: 10.1002/ibd.20042

    4. Apolipoprotein A-IV is an independent predictor of disease activity in patients with inflammatory bowel disease (pages 391–397)

      Uli C. Broedl, Veronika Schachinger, Arno Lingenhel, Michael Lehrke, Renee Stark, Frank Seibold, Burkhard Göke, Florian Kronenberg, Klaus G. Parhofer and Astrid Konrad-Zerna

      Version of Record online: 19 DEC 2006 | DOI: 10.1002/ibd.20078

    5. Genetic risk factors in patients with inflammatory bowel disease and vascular complications: Case-control study (pages 410–415)

      I.E. Koutroubakis, A. Sfiridaki, G. Tsiolakidou, A. Theodoropoulou, A. Livadiotaki, G. Paspatis and E.A. Kouroumalis

      Version of Record online: 19 DEC 2006 | DOI: 10.1002/ibd.20076

    6. Inflammation is the main determinant of low bone mineral density in pediatric inflammatory bowel disease (pages 416–423)

      Massimiliano Paganelli, Carlina Albanese, Osvaldo Borrelli, Fortunata Civitelli, Nicoletta Canitano, Franca Viola, Roberto Passariello and Salvatore Cucchiara

      Version of Record online: 19 DEC 2006 | DOI: 10.1002/ibd.20039

    7. Active and passive smoking in childhood is related to the development of inflammatory bowel disease (pages 431–438)

      Suhal S. Mahid, Kyle S. Minor, Arnold J. Stromberg and Susan Galandiuk

      Version of Record online: 19 DEC 2006 | DOI: 10.1002/ibd.20070

    8. How adherent to treatment with azathioprine are patients with Crohn's disease in long-term remission? (pages 446–450)

      Gerassimos J. Mantzaris, Anastasios Roussos, Chryssostomos Kalantzis, Stavroula Koilakou, Nickolaos Raptis and Nickolaos Kalantzis

      Version of Record online: 19 DEC 2006 | DOI: 10.1002/ibd.20041

    9. Estimation of the period prevalence of inflammatory bowel disease among nine health plans using computerized diagnoses and outpatient pharmacy dispensings (pages 451–461)

      Lisa J. Herrinton, Liyan Liu, Jennifer Elston Lafata, James E. Allison, Susan E. Andrade, Eli J. Korner, K. Arnold Chan, Richard Platt, Deborah Hiatt and Siobhán O'Connor

      Version of Record online: 11 JAN 2007 | DOI: 10.1002/ibd.20021

    10. Health-related quality of life after ileocolonic resection for Crohn's disease: Long-term results (pages 462–469)

      Marco Scarpa, Cesare Ruffolo, Renata D'Incà, Teresa Filosa, Eugenia Bertin, Stefania Ferraro, Lino Polese, Alessandro Martin, Giacomo C. Sturniolo, Mauro Frego, Davide F. D'Amico and Imerio Angriman

      Version of Record online: 19 DEC 2006 | DOI: 10.1002/ibd.20080

    11. Quality-of-life measurement in patients with inflammatory bowel disease receiving social support (pages 470–474)

      S. Oliveira, C. Zaltman, C. Elia, R. Vargens, A. Leal, R. Barros and H. Fogaça

      Version of Record online: 19 DEC 2006 | DOI: 10.1002/ibd.20071

    12. Clinical epidemiology of inflammatory bowel disease in Lebanon (pages 475–480)

      Heitham Abdul-Baki, Ihab ElHajj, Lara MN El-Zahabi, Cecilio Azar, Elie Aoun, Hala Zantout, Walid Nasreddine, Bassem Ayyach, Fadi H. Mourad, Assaad Soweid, Kassem A. Barada and Ala I. Sharara

      Version of Record online: 19 DEC 2006 | DOI: 10.1002/ibd.20022

    13. Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: A population-based study from Copenhagen, Denmark (pages 481–489)

      Tine Jess, Lene Riis, Ida Vind, Karen Vanessa Winther, Sixten Borg, Vibeke Binder, Ebbe Langholz, Ole ØStergaard Thomsen and Pia Munkholm

      Version of Record online: 19 DEC 2006 | DOI: 10.1002/ibd.20036

  2. Basic Science Review

    1. Top of page
    2. Original Articles
    3. Basic Science Review
    4. Selected Summaries
    5. Letters to the Editor
  3. Selected Summaries

    1. Top of page
    2. Original Articles
    3. Basic Science Review
    4. Selected Summaries
    5. Letters to the Editor
  4. Letters to the Editor

    1. Top of page
    2. Original Articles
    3. Basic Science Review
    4. Selected Summaries
    5. Letters to the Editor
    1. Antibodies against cyclic citrullinated peptide (CCP) in inflammatory bowel disease patients with or without arthritic manifestations (pages 504–505)

      Ioannis E. Koutroubakis, Konstantinos Karmiris, Leonidas Bourikas, Elias A. Kouroumalis, Ioannis Drygiannakis and Dimitrios Drygiannakis

      Version of Record online: 19 DEC 2006 | DOI: 10.1002/ibd.20038

    2. Use of an intravascular thrombectomy device to treat life-threatening venous thrombosis in a patient with Crohn's disease and G20210A prothrombin gene mutation (pages 505–508)

      G.S. Latzman, A. Kornbluth, S.J. Murphy, P. Legnani, J. George, J. Guller, S. Lewin, A. Carroccio and M.T. Harris

      Version of Record online: 21 DEC 2006 | DOI: 10.1002/ibd.20037

    3. Occult hepatitis B and infliximab-induced HBV reactivation (pages 508–509)

      Salvatore Madonia, Ambrogio Orlando, Daniela Scimeca, Mirko Olivo, Francesca Rossi and Mario Cottone

      Version of Record online: 19 DEC 2006 | DOI: 10.1002/ibd.20035

    4. Refractory and infected pyoderma gangrenosum in a patient with ulcerative colitis: Response to infliximab (pages 509–510)

      F. De la Morena, L. Martín, J.P. Gisbert, J. Fernández Herrera and R. Goiriz

      Version of Record online: 21 DEC 2006 | DOI: 10.1002/ibd.20081

SEARCH

SEARCH BY CITATION